Skip to main content
Clinical Trials/IRCT20220302054164N2
IRCT20220302054164N2Not yet recruitingPhase 3

The effect of intravenous infusion of remifentanil and dexmedetomidine on hemodynamic changes and pain in patients undergoing cataract surgery

Arak University of Medical Sciences0 sites122 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Enrollment
122

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
25 years to 75 years (—)
Sex
All

Inclusion Criteria

  • All patients referred to Amirkabir Arak Hospital for cataract surgery
  • signing informed consent by patients
  • Patients age 25-75 years
  • American Society of Anesthesiologists (ASA) physical status classification I & II
  • Candidates of local anesthesia

Exclusion Criteria

  • Not provided

Investigators

Similar Trials

The effect of intravenous infusion of... | Clinical Trial